Back to Results
First PageMeta Content
Lactams / Benign prostatic hyperplasia / Lower urinary tract symptoms / Dutasteride / Finasteride / Prostate cancer / Prostate / Urinary retention / 5-alpha-reductase inhibitor / Medicine / Anatomy / Andrology


Mm 1 to_Esophagus[removed])
Add to Reading List

Document Date: 2015-03-05 06:30:58

Open Document

File Size: 216,13 KB

Share Result on Facebook

City

Helsinki / Fosså / IPSS / Chicago / Bucharest / /

Company

Pearson / European Social Fund / SPSS / Social Sciences Inc. / GE / /

Country

Romania / United States / /

Currency

pence / /

/

Facility

University of Medicine / MD Clinical Hospital of Emergency St / The Bucharest University of Economic Studies / Romania Clinical Hospital of Emergency St. John / Laboratory Methods / Clinical Hospital of Infectious / Pharmacy Carol Davila / /

IndustryTerm

treatment of benign prostatic hyperplasia / therapeutic protocol / /

MedicalCondition

benign prostatic hypertrophy / BPH / disease / urinary retention / erectile dysfunction / neurogenic bladder / chronic / prostatic hypertrophy / Allergy / hybridoma growth factor/ plasmacytoma / chronic inflammation / diseases / disorder / Benign prostatic hyperplasia / infection / prostate cancer / inflammation / infections / alcoholism / inflammatory / disorders / gynecomastia / symptomatic benign prostatic hyperplasia / /

MedicalTreatment

Chemoprevention / surgical treatment / phytotherapy / /

Organization

Clinical Hospital of Infectious / Bucharest University / Romania Clinical Hospital of Emergency St. John / University of Medicine / /

Person

Bruce S. Bocher / Corina Daniela / Cosmin-Victor Ene / Kirby R. Benign / Immunology / Victor Babeæ / Oana Andreia / /

Position

author / coordinator / Major / surgeon / /

Product

finasteride / IL-6 Prostate / tamsulosin / testosterone / IL-6 / /

ProvinceOrState

South Dakota / Arkansas / /

Technology

therapeutic protocol / alpha / standardized protocol / ale / /

SocialTag